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Abstract
Background: Due to the increase of solar ultraviolet radiation (UV) incidence over the last few decades, the use of sunscreen
has been widely adopted for skin protection. However, considering the high efficiency of sunlight-induced DNA lesions, it is
critical to improve upon the current approaches that are used to evaluate protection factors. An alternative approach to
evaluate the photoprotection provided by sunscreens against daily UV radiation-induced DNA damage is provided by the
systematic use of a DNA dosimeter.
Methodology/Principal Findings: The Sun Protection Factor for DNA (DNA-SPF) is calculated by using specific DNA repair
enzymes, and it is defined as the capacity for inhibiting the generation of cyclobutane pyrimidine dimers (CPD) and oxidised
DNA bases compared with unprotected control samples. Five different commercial brands of sunscreen were initially
evaluated, and further studies extended the analysis to include 17 other products representing various formulations and
Sun Protection Factors (SPF). Overall, all of the commercial brands of SPF 30 sunscreens provided sufficient protection
against simulated sunlight genotoxicity. In addition, this DNA biosensor was useful for rapidly screening the biological
protection properties of the various sunscreen formulations.
Conclusions/Significance: The application of the DNA dosimeter is demonstrated as an alternative, complementary, and
reliable method for the quantification of sunscreen photoprotection at the level of DNA damage.
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Introduction
The range of sunlight corresponding to UVB (290–320 nm) and
UVA (320–400 nm) wavelengths is the cause of numerous adverse
skin effects, such as sunburn, skin aging and the induction of skin
cancer [1]. The observation that squamous and basal-cell
carcinomas develop almost exclusively in sunlight-exposed areas
in individuals who rarely tan or burn easily is clear evidence of the
relationship between sun exposure and the occurrence of skin
cancers [2–3]. These adverse effects are even more evident when
considering the induction of the often fatal cutaneous malignant
melanoma. This disease has recently displayed a significant
increase with an incidence that has more than doubled over the
past 25 years [4].
Sunlight carcinogenesis is linked to a chain of events following
exposure that includes the induction of DNA damage and
subsequent mutation [5]. Notably, different wavelengths of UV
light induce several types of DNA damage [6]. Direct excitation
of DNA molecules, mainly by UVB wavelength light, gives rise
to well-known photochemical reactions that lead to the formation
of DNA photoproducts that are known as cyclobutane pyrimi-
dine dimers (CPDs) and pyrimidine (6–4) pyrimidone photo-
products (6-4PPs) [7–9].
Apart from the direct induction of DNA photoproducts, UV
radiation can also indirectly give rise to DNA damage through
UVA photon absorption by other chromophores and the
subsequent generation of reactive oxygen species [2]. Oxidised
DNA bases, such as 7,8-dihydro-8-oxoguanine, have often been
proposed to be pre-mutagenic lesions in UVA mutagenesis [2,10–
14]. In contrast, recent studies suggest that CPD is the most
relevant UVA-induced type of DNA lesion observed in various
biological models, such as purified DNA samples [9], cultured cells
[15] and whole-skin explants [6]. Recently, in vivo assaying
revealed that UVA1 (340–400 nm) induces CPDs in the skin of
healthy volunteers, indicating that UVA radiation may be more
carcinogenic than previously assumed [16].
With regards to public health-care, photoprotection has become
a topic for increased attention, and the use of sunscreen lotions is
widely considered to be one of the main defense mechanisms
against the harmful effects of UV radiation. The evaluation of
protection efficiency occurs mainly through the induction of
erythema in human skin and is expressed as a sun protection factor
(SPF). In addition to SPF, other UVA protection parameters, such
as in vivo Persistent Pigment Darkening (PPD) and in vitro UVA-PF,
have recently been introduced. An important issue that relates to
biological relevance is that these parameters do not reflect other
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deleterious effects of UV radiation, such as immunosuppression,
photoaging and carcinogenesis [1]. Furthermore, it is evident that
personal exposure time is directly influenced by the labelled SPF,
with people using sunscreens to prolong intentional sun exposure
[17].
The high prevalence of UV-related diseases makes the need for
methodologies that use molecular approaches critical to comple-
ment the current approaches that evaluate sun protection and to
accurately inform consumers as to the photoprotection efficacy of
commercial sunscreens. Because DNA is the main target of solar
UV-radiation in living cells and DNA photoinduced lesions are a
prerequisite for triggering several biological skin effects, evaluation
of the protection that is provided against DNA-induced damage
would be a worthy parameter to complement the limitations of
current approaches. Ample evidence of DNA protection offered by
sunscreen exists and has been demonstrated using various models,
such as the skin of human volunteers [18], mice [19], human skin
explants [1], a reconstructed human skin model [18,20], and in
vitro cultured human cells [21–23]. In this study, a simple and
robust in vitro approach is proposed for rapid screening of
photoprotection against the induction of several types of DNA
lesions after exposure to simulated solar UV radiation. This
strategy is based on the exposure of a highly UV-transparent
DNA-based biosensor to a solar simulator [9]. The Sun Protection
Factor for DNA (DNA-SPF), calculated by using the DNA repair
enzymes E. coli formamidopyrimidine-DNA glycosylase (Fpg;
recognizes mainly oxidatively generated damage in purines) and
T4 bacteriophage endonuclease V (T4-endo V; specific for CPDs),
includes the fold protection provided by the sunscreen against the
induction of both CPDs and oxidised DNA bases compared with
unprotected DNA samples.
Figure 1. Determination and quantification of DNA lesions after exposure to a solar simulator. Treatment with the DNA repair enzymes
T4-endo V (A) or Fpg (B). The number of DNA lesions induced by simulated sunlight in the absence (vehicle) or presence of five different
commercially available SPF 30 sunscreens (C). FI (supercoiled plasmid DNA bands); FII (open-circular relaxed DNA bands); T4-endo V-SS (T4-endo V
sensitive sites – CPDs); Fpg-SS (Fpg sensitive sites – oxidised DNA bases). The average and standard deviation from three independent experiments
are shown. The experiments were performed in triplicate.
doi:10.1371/journal.pone.0040344.g001
Sunscreen Efficacy by DNA Damage Evaluation
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By using a DNA dosimeter that is complementary to the
labelled SPF, it was possible to demonstrate the important DNA
damage protection profiles that are provided by various commer-
cial products and sunscreen formulations following exposure to
daily simulated sunlight, which is comparable to prevailing
tropical conditions.
Results
DNA Photoprotection Properties of five Different Brands
of Commercially Available SPF 30 Sunscreens
Exposure of the DNA-based biosensor was carried out in a solar
simulator to mimic two hours of sun exposure on a clear-sky
summer day in Sa˜o Paulo (23u329S; 46u389W), the largest city in
Brazil, and one of the most populous cities in the world. To do so,
DNA dosimeters were irradiated for 2:06 hours, which correspond
to 300,000 J/m2 of simulated solar UV radiation. This simulated
irradiation was therefore consistent with the environmentally
observed UV dose under similar conditions in which the natural
solar UV dose measured from 11:00 a.m. to 13:15 p.m. (2:15
hours) corresponds to 300,861 J/m2.
Initially, five brands of commercial SPF 30 sunscreens were
homogeneously applied to the surface of the DNA dosimeters to
be irradiated. After exposure to the solar simulator, plasmid
DNA samples were first treated with DNA repair enzymes (Fpg
and T4-endo V) to quantify the number of specific DNA lesions
(Fpg-SS, Fpg sensitive sites; T4-endo V-SS, T4-endo V sensitive
sites). Electrophoretic migration in agarose gels distinguished
supercoiled DNA (form I – FI; free from UV-induced DNA
damage) from open-circular relaxed DNA that contained breaks
or nicks caused by enzymatic cleavage after recognition of the
specific UV-induced DNA damage (form II – FII). Illustration of
these experiments and the quantification of CPDs and oxidised
DNA damage after exposure to solar simulator are presented in
Figure 1.
There was a notable decrease in the amount of DNA damage
(DNA from II – FII) in samples that were protected by each of the
SPF 30 sunscreens as compared to the vehicle control. Although
Fpg-SS was not as efficiently induced as T4-endo V-SS, it was still
possible to observe a reduction in the number of oxidised DNA
bases in the irradiated samples, as well as a reduction of CPDs,
under experimental conditions. DNA-SPF values, as well as the
percentage of DNA photoprotection, and the protection provided
against the induction of each type of DNA lesion are presented in
Table 1.
Although the DNA-SPFs were slightly lower than labelled SPFs,
all of the tested products appear to offer satisfactory protection
against the genotoxic impact induced by simulated exposure to the
midday sun at the Sa˜o Paulo latitude. No statistically significant
differences were observed among DNA photoprotection properties
provided by the commercial SPF 30 sunscreens that were
evaluated in this study (p,0.05).
DNA Photoprotection Properties Provided by 17
Different Sunscreen Formulations
To demonstrate the applicability of the biological dosimeter
to the rapid assessment of DNA photoprotection properties of
products containing UV filters, the study was extended to
evaluate 17 different sunscreen formulations that included
creamy emulsion, fluid emulsion, alcoholic gel and alcoholic
fluid, as well as 8 SPFs (1.5, 5, 14, 15, 30, 34, 50, and 60). The
subsequent quantification of CPDs and oxidised DNA bases that
were induced under simulated sunlight conditions are presented
in Figure 2.
In general, products with high SPF values offered better
protection against the generation of T4-endo V-SS and Fpg-SS.
The protection provided by each sunscreen against the induction
of these two types of DNA lesions was assessed by quantifying
DNA damage, DNA-SPF values, and the percentage of DNA
photoprotection. These results are presented in Table 2.
Most of the tested formulations proved to be highly efficient in
protecting DNA samples, consistent with their high DNA-SPF
values. Some of these values were similar to or even higher than
their respective labelled SPFs. Curiously enough, photoprotection
against oxidised DNA bases was the most heterogeneous sunscreen
attribute. Moreover, high levels of DNA photoprotection could be
observed for most products, consistent with the high levels of CPD
photoprotection (the most frequent type of sunlight-induced DNA
lesion) provided by those sunscreens.
To better distinguish the degree of genotoxic protection
provided by each sample, the efficacy of the 17 formulations was
compared by statistical analysis with subsequent grouping based
on their individual efficacies in hindering the generation of DNA
damage (for both CPD and oxidised DNA bases). The results of
these analyses are presented in Table 3. Figure 3 illustrates the
correlation between the percentage of DNA photoprotection (for
both CPDs and oxidised DNA bases) and labelled SPF.
The results confirm the relationship between DNA photo-
protection and labelled SPF and imply that the increased
genotoxic protection of a specific product should coincide with
an increase in its labelled SPF value, independently of the
formulation structure.
Table 1. DNA photoprotection properties provided by five brands of SPF 30 sunscreens.
Products DNA-SPF % DNA photoprotection (95% CI) % CPD photoprotection (95% CI)
% Oxidised DNA bases
photoprotection (95% CI)
SPF 30 brand 1 20.0 95.2 (94.6 to 95.7) 95.7 (95.1 to 96.3) 91.1 (90.5 to 91.7)
SPF 30 brand 2 20.3 95.1 (94.7 to 95.3) 97.4 (97.2 to 97.6) 76.6 (75.0 to 78.1)
SPF 30 brand 3 16.8 94.0 (93.6 to 94.4) 96.0 (95.9 to 96.1) 78.9 (76.0 to 81.8)
SPF 30 brand 4 16.9 94.1 (92.9 to 95.2) 96.0 (95.9 to 96.2) 78.6 (70.3 to 86.9)
SPF 30 brand 5 20.9 95.2 (94.2 to 96.2) 96.2 (95.4 to 97.0) 87.5 (86.1 to 89.0)
Legend: DNA-SPF – Sun Protection Factor for DNA; %DNA photoprotection – percentage of DNA photoprotection; % CPD photoprotection – percentage of protection
against CPDs; % oxidised DNA base photoprotection – percentage of protection against oxidised DNA bases; and 95% CI –95% confidence interval of three
independent experiments performed in triplicate.
doi:10.1371/journal.pone.0040344.t001
Sunscreen Efficacy by DNA Damage Evaluation
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Discussion
Because UV exposure is considered to be the main cause of
clinical alterations in sun-exposed skin, an accurate estimate of the
photoprotection provided by sunscreen is a major concern in the
prevention of the hazardous consequences of prolonged sun
exposure. Currently, two major approaches are used in the
cosmetic industry when defining the protection properties of
sunscreens. These approaches include SPF, which measures
erythema induction in the UVB range, and PPD, which measures
the oxidation of melanin precursors in the UVA. However, in both
Figure 2. DNA lesions induced by simulated sunlight in the absence (vehicle) or presence of 17 sunscreens. T4-endo V-SS (T4-endo V
sensitive sites – CPDs); Fpg-SS (Fpg sensitive sites – oxidised DNA bases). The average and standard deviation in three independent experiments are
shown. The experiments were performed in triplicate.
doi:10.1371/journal.pone.0040344.g002
Table 2. DNA photoprotection properties provided by 17 different sunscreen formulations.
Products DNA-SPF
% DNA photoprotection (95%
CI)
% CPD photoprotection (95%
CI)
% Oxidised DNA bases
photoprotection (95% CI)
Creamy emulsion SPF 1.5 1.5 35.0 (33.6 to 36.4) 38.4 (35.6 to 41.2) 70.7 (68.4 to 73.0)
Creamy emulsion SPF 5 9.2 89.0 (87.8 to 90.2) 92.8 (91.4 to 94.2) 47.8 (33.5 to 61.3)
Creamy emulsion SPF 15 9.9 89.9 (89.5 to 90.3) 93.8 (93.4 to 94.2) 54.8 (52.8 to 56.8)
Fluid emulsion SPF 15 10.7 90.6 (90.3 to 90.9) 93.4 (92.8 to 94.0) 57.3 (54.1 to 60.5)
Alcoholic gel SPF 15 11.4 91.2 (90.9 to 91.5) 93.6 (93.1 to 94.1) 64.1 (62.3 to 65.9)
Creamy emulsion SPF 14 13.6 92.6 (92.5 to 92.7) 95.0 (94.7 to 95.3) 64.8 (64.2 to 67.4)
Facial creamy emulsion SPF 30 12.5 91.9 (91.1 to 92.7) 92.9 (92.4 to 93.4) 87.9 (85.6 to 90.2)
Alcoholic gel SPF 30 17.5 94.2 (93.6 to 94.8) 95.1 (94.7 to 95.5) 87.9 (86.3 to 89.5)
Creamy emulsion SPF 30 18.7 94.4 (95.0 to 93.8) 95.3 (94.9 to 95.7) 88.0 (85.9 to 90.1)
Fluid emulsion SPF 30 19.1 94.8 (94.6 to 95.0) 96.8 (96.5 to 97.1) 75.9 (74.6 to 77.2)
Alcoholic fluid SPF 30 21.8 95.4 (95.2 to 95.6) 95.8 (95.5 to 96.1) 95.0 (94.8 to 95.2)
Creamy emulsion SPF 50 40.2 97.5 (97.2 to 97.8) 98.9 (98.8 to 99.0) 76.0 (75.0 to 77.1)
Alcoholic fluid SPF 60 41.8 97.5 (96.9 to 98.1) 99.2 (99.0 to 99.4) 72.3 (68.3 to 76.4)
Creamy emulsion kids SPF 60 45.7 97.8 (97.7 to 97.9) 98.1 (98.0 to 98.2) 93.3 (92.8 to 93.8)
Creamy emulsion SPF 60 100.7 99.0 (99.2 to 98.8) 99.2 (99.1 to 99.3) 96.6 (95.7 to 97.6)
Creamy emulsion SPF 34 134.5 99.2 (99.0 to 99.4) 99.5 (99.4 to 99.6) 95.9 (94.9 to 96.9)
Facial creamy emulsion SPF 60 160.1 99.4 (99.2 to 99.5) 99.6 (99.5 to 99.7) 96.0 (94.9 to 97.0)
Legend: DNA-SPF – Sun Protection Factor for DNA; % DNA photoprotection – percentage of DNA photoprotection; % CPD photoprotection – percentage of protection
against CPDs; % oxidised DNA base photoprotection – percentage of protection against oxidised DNA bases; and 95% CI –95% confidence interval of three
independent experiments performed in triplicate.
doi:10.1371/journal.pone.0040344.t002
Sunscreen Efficacy by DNA Damage Evaluation
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cases the measurements consist of skin responses that are not
related to the induction of skin cancer [1].
There is an urgent need for complementary methodologies to
overcome the existing limitations of the current approaches for
measuring photoprotection. Therefore, we propose the use of a
highly UV transparent DNA dosimeter to evaluate sunscreen
photoprotection against the induction of CPDs and oxidised DNA
bases by simulated sunlight. The rationale for choosing both T4-
endo V and Fpg enzymes is to facilitate the quantification and
qualification of the broad scope of biological protection and the
inhibition of different types of natural sunlight-induced DNA
damage bestowed by a specific sunscreen.
Another common recurring issue regarding accurate consumer
information is the importance of evaluating the photoprotection
efficiency of sunscreens in the context of midday sun exposure as a
result of prolonged exposure during either occupational or
recreational circumstances [1,24]. The total UV dose and the
time of irradiation in the solar simulator that were used in this
study were very similar to observed data of natural solar UV
radiation around midday on a clear summer day at the Sa˜o Paulo
latitude.
Following the verification of these important parameters, five
commercial brands of SPF 30 sunscreen were first irradiated under
these conditions, followed by treatment with the DNA repair
enzymes (Figure 1). Briefly, all of the tested products efficiently
protected against T4-endo V-SS and Fpg-SS induction compared
with the unprotected irradiated DNA samples (vehicle), thus
demonstrating high levels of DNA photoprotection against
simulated solar UV radiation (Table 1). Moreover, all of the
samples displayed similar levels of DNA photoprotection with no
statistically significant differences (p,0.05).
The study was further extended to evaluate the DNA
photoprotection properties of 17 products containing UV filters.
It was dramatically clear that, after exposure to the solar simulator,
the majority of sunscreens efficiently reduced the amount of T4-
endo V-SS and Fpg-SS (Figure 2). High DNA-SPF values were
determined, with some values similar to or higher than their
corresponding SPF labels (Table 2). Lower DNA-SPFs were
observed for products that only listed UVA filters in their
formulation, such as Creamy emulsion SPF 1.5 and Creamy
emulsion SPF 5. In contrast, Creamy emulsion SPF 14 exhibited a
Table 3. ANOVA and Tukey tests for efficacy discrimination of 17 different sunscreen formulations.
Products
Estimated Average of DNA lesions (CPDs +
oxidised DNA bases) Groups
Vehicle 1.633 A
Creamy emulsion SPF 1.5 1.061 B
Creamy emulsion SPF 5 0.179 C
Creamy emulsion SPF 15 0.155 C D
Fluid emulsion SPF 15 0.153 C D
Alcoholic gel SPF 15 0.143 C D
Facial creamy emulsion SPF 30 0.132 C D E
Creamy emulsion SPF 14 0.120 D E F
Alcoholic gel SPF 30 0.094 E F G
Creamy emulsion SPF 30 0.091 E F G
Fluid emulsion SPF 30 0.081 F G H
Alcoholic fluid SPF 30 0.075 G H I
Creamy emulsion SPF 50 0.041 H I J
Alcoholic fluid SPF 60 0.040 H I J
Creamy emulsion kids SPF 60 0.036 I J
Creamy emulsion SPF 60 0.016 J
Creamy emulsion SPF 34 0.012 J
Facial creamy emulsion SPF 60 0.010 J
Legend: Statistical analysis were performed according to the individual efficacy in hindering the generation of DNA damage (CPD and oxidised DNA bases) with
subsequent grouping (p,0.05). Increases in the protection efficiency are listed in alphabetical order (A , B , C , D , E , F , G , H , I , J). Statistically significant
differences were observed among samples from the different groups, however this was not the case among samples within the same group. Three independent
experiments were performed in triplicate.
doi:10.1371/journal.pone.0040344.t003
Figure 3. Correlation between the percentages of DNA
photoprotection and the labelled SPF values of 17 sunscreen
formulations.
doi:10.1371/journal.pone.0040344.g003
Sunscreen Efficacy by DNA Damage Evaluation
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higher DNA-SPF than other SPF 15 sunscreens, including Facial
creamy emulsion SPF 30. Interestingly, Creamy emulsion SPF 34
displayed higher protection for both CPDs and oxidised DNA
bases when compared to sunscreens with an SPF of 30 and 50 and
even higher than some sunscreens with an SPF of 60. Both of these
products only have UVB filters in their formulations. The results
are in agreement with a previous study in which it was shown that
the UVB filter in the formulation was more efficient in protecting
against the generation of both CPD and 8-hydroxy-29-deoxygua-
nosine than the UVB + UVA combination sunscreens [18].
Together, we have shown that the levels of oxidised DNA base
photoprotection provided by the sunscreens examined in this study
were lower than the levels of CPDs photoprotection. These results
suggest that, in general, sunscreens are more efficient in protecting
against the direct formation of pyrimidine dimers than against the
generation of oxidised DNA bases, which are formed by indirect
mechanisms following the absorption of long UVA wavelengths
[25].
With the goal of distinguishing the protective properties of 17
sunscreen formulations by group, a statistical comparison of the
individual sunscreen efficacy in reducing the amount of DNA
lesions (CPDs and oxidised DNA bases) relative to that observed in
unprotected control samples (vehicle) (Table 3) revealed a direct
relationship between the labelled SPF value and genotoxic
protection, indicating that an increase in DNA photoprotection
conferred by a specific product would be in accordance with a
higher specified SPF, independent of formulation structure
(Figure 3). Furthermore, these results indicate the usefulness of
the biosensor for validating the DNA photoprotection properties
of various sunscreen formulations.
The main limitation observed in this in vitro system resides in the
inability to simulate the three-dimensional structural conditions of
the skin, as other models using either artificial reconstructed skin
[20,26] or skin explants [1] do. However, these systems also
include certain limitations, mainly with regards to the availability
of donor tissues and the elevated costs of working with numerous
samples or expensive equipment. These methods also require well-
trained personnel that are equipped to run specific machinery or
the production of large amounts of artificially reconstructed skin
with accuracy and reproducibility.
Furthermore, this system presents certain advantages relevant to
applications in the cosmetics industry and is complementary to the
current SPF, PPD, and UVA-PF approaches. These advantages
include the use of a highly UV-transparent apparatus with a well-
defined transmittance spectrum to undertake the exposure of DNA
samples to UV sources (Figure 4), the ability to evaluate several
products simultaneously in a very simple, easy-to-handle, and cost
effective manner, the possibility of testing sunscreens under natural
conditions through direct exposure to natural sunlight at different
latitudes [27], and the use of various DNA lesion biomarkers
(specific enzymes or antibodies) that can be easily standardized. It
is important to add that a similar in vitro system, employing
cultured human cells, for the measurement of DNA damage and
cell sensitivity is being developed. DNA repair proficient and
deficient cells are being employed which improves the sensitivity of
this new system. This work is in progress, and basically validates
the usefulness of this approach to assess sunscreen genotoxic
photoprotection, as well as it may provide important specific
information for people with hypersensitivity to sunlight. Therefore,
this work demonstrates that the DNA dosimeter system efficiently
measures the amount and nature of specific DNA lesions that are
induced by simulated sunlight, as well as the molecular level of
photoprotection provided by various commercial products and
sunscreen formulations.
Material and Methods
Plasmid
Plasmid DNA samples (pCMUT vector, 1762 bp) were purified
using the Qiagen Plasmid Maxi Kit (Valencia, CA) with freshly
transformed E. coli strain DH10b [9]. The resulting samples were
stored in a TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA)
at 220uC prior to the initiation of experiments.
The DNA Dosimeter System
The DNA dosimeter apparatus was produced using a special
frame developed with the very high UV-transparent Elastomer
Syslgard 184 Kit (Dow Corning Corporation, Midland, MI)
because this product includes important and adequate features
for the exposure of DNA samples to natural or artificial sources of
UV radiation [9]. DNA samples were applied in triplicate inside
the prototype for the desired exposure times. The DNA dosimeter
provides a reliable and reproducible way to calculate the
biologically effective dose (BED) of UV radiation by quantifying
the amount of specific DNA lesions generated by a specific
exposure. This biosensor was previously demonstrated to represent
a valid biological dosimeter for assessing photo-induced DNA
damage [9,14,27–28]. Figure 4 illustrates the transmittance
spectrum of the DNA dosimeter, as well as its usefulness for
collectively evaluating the DNA photoprotection properties of
several products that include sunscreen.
Solar Simulator Irradiation of the DNA Dosimeter in the
Presence or Absence of Sunscreen
The DNA dosimeter was exposed to 300,000 J/m2 of solar
simulated UV radiation using an Atlas Ci400 Xenon Weather-
OmeterH solar simulator (Chicago, IL) in the presence or absence
of sunscreen. The maximum temperature and relative air
humidity measured inside the solar simulator were 40uC and
65%, respectively. The daily UV dose that was used as a reference
in the current study was measured under midday sun on a clear-
sky summer day in Sa˜o Paulo, Brazil (23u329S; 46u389W) with
specific UVB/UVA radiometers (UVB and UVA Radiometers,
EKO Instruments Trading Co., Ltda., Japan). Before each
irradiation, sunscreens were homogeneously spread onto the
surface of the biosensor with a fine brush at a density of 2 mg/
cm22, following the recommendations from the COLIPA/CTFA-
SA/JCIA/CTFA International Sun Protection Factor (SPF) Test
Method Guideline [29]. A weighing method was used to ensure
reproducibility, as indicated by this guideline.
DNA Photoproduct Quantification
After separation by 0.8% agarose gel electrophoresis, the
relative amounts of supercoiled and open-circular relaxed plasmid
DNA were measured by densitometry analysis (ImageQuant - GE
Healthcare, Little Chalfont, UK). Samples with 200 ng of DNA
were pre-incubated with 0.8 U of Fpg protein (New England
Biolabs, Ipswich, MA) and 70 ng of T4-endo V (produced in this
laboratory) prior to discriminating between the different DNA
lesions. The samples were then incubated at 37uC for 60 minutes.
The enzymes, which were previously assayed at concentrations
reaching saturation, were used at concentrations at which no non-
specific cleavage is observed. The number of enzyme-sensitive sites
per kbp of plasmid DNA was calculated, assuming Poisson
distribution that was adapted for this technique, by the following
equation:
X~{ln 1:4|FI= 1:4|FIzFIIð Þð Þ=1:8
Sunscreen Efficacy by DNA Damage Evaluation
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where FI represents the intensity of fluorescence measured in the
supercoiled DNA bands, FII represents the intensity in the open-
circular relaxed DNA bands, 1.4 is a correction factor to account
for the increased fluorescence of ethidium bromide when this
compound is bound to relaxed DNA compared to supercoiled
DNA, and 1.8 is pCMUT vector size in Kbp [30]. The number of
DNA lesions calculated for the irradiated DNA samples were
subtracted from the number of breaks observed in the non-
irradiated control samples.
The Sun Protection Factor for DNA (DNA-SPF) and its
Percentage of DNA Photoprotection
The calculation of DNA-SPF, adapted from the COLIPA/
CTFA-SA/JCIA/CTFA International Sun Protection Factor
(SPF) Test Method Guideline [29], was determined as the
arithmetical mean of the individual DNA-SPF (DNA-SPFi) values
obtained from the total number (n) of UV irradiations by the
following equation:
DNA{SPF~
X
DNA{SPFi
 
=n
where DNA-SPFi is calculated by the ratio between the total
amount of DNA lesions (CPDs + oxidised DNA bases) induced by
UV light in each plasmid DNA sample without sunscreen and the
total amount of DNA damage verified in each irradiated sample in
the presence of sunscreen.
With regards to the variability of the induction of different types
of DNA lesions by sunlight, the calculation of the percentage of
DNA photoprotection provides a simple and clear approach with
which to qualify the biological protection of a specific DNA-SPF.
The individual percentage of DNA photoprotection is determined
as the weighted arithmetic average of the percentages of protection
for both CPDs (CPD photoprotection) and oxidised DNA bases
(oxidised DNA bases photoprotection) in each irradiated DNA
sample. The total percentage of DNA photoprotection is then
determined as the arithmetical mean of individual percentages of
DNA photoprotection obtained from the total number of UV
irradiations.
Statistical Analysis
All of the products examined in this study were mutually
discriminated by ANOVA and Tukey tests (p,0.05) according to
their individual DNA photoprotection efficacy. For the 17
products presenting different formulations and labelled SPF
values, these were further separated into groups based on their
individual efficacies in hindering the generation of DNA damage
(for both CPD and oxidized DNA bases). Increases in the
protection efficiency were listed in alphabetical order (A , B ,
C , D , E , F , G , H , I , J). Statistically significant
differences were observed among samples from the different
groups, however this was not the case among samples within the
same group. Additionally, a correlation analysis was performed
between the percentages of DNA photoprotection (for both CPD
and oxidised DNA bases) and labelled SPF values of all the 17
products presenting different formulations of sunscreen. Addinsoft
XLSTAT (Belmont, MA) was used for the statistical tests.
Figure 4. Assessment of the genotoxic protection properties of sunscreens by DNA dosimetry. Exposure of DNA dosimeters to a solar
simulator for simultaneously evaluation of DNA photoprotection efficacy of several products containing sunscreen (A). The DNA dosimeter
transmittance spectrum (B).
doi:10.1371/journal.pone.0040344.g004
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